Why Clinically Used Tazobactam and Sulbactam Are Poor Inhibitors of OXA-10 β-Lactamase: Raman Crystallographic Evidence†

Title
Why Clinically Used Tazobactam and Sulbactam Are Poor Inhibitors of OXA-10 β-Lactamase: Raman Crystallographic Evidence†
Authors
Keywords
-
Journal
BIOCHEMISTRY
Volume 47, Issue 13, Pages 4094-4101
Publisher
American Chemical Society (ACS)
Online
2008-03-07
DOI
10.1021/bi702348w

Ask authors/readers for more resources

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now